These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 28704492

  • 1. Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.
    Mailankody S, Dangeti GV, Soundravally R, Joseph NM, Mandal J, Dutta TK, Kadhiravan T.
    PLoS One; 2017; 12(7):e0181262. PubMed ID: 28704492
    [Abstract] [Full Text] [Related]

  • 2. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
    Matsuura E, Umehara F, Hashiguchi T, Fujimoto N, Okada Y, Osame M.
    J Neurol Sci; 2000 Feb 01; 173(1):45-52. PubMed ID: 10675579
    [Abstract] [Full Text] [Related]

  • 3. Pathophysiology and prognosis in vietnamese adults with tuberculous meningitis.
    Thwaites GE, Simmons CP, Than Ha Quyen N, Thi Hong Chau T, Phuong Mai P, Thi Dung N, Hoan Phu N, White NP, Tinh Hien T, Farrar JJ.
    J Infect Dis; 2003 Oct 15; 188(8):1105-15. PubMed ID: 14551879
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo.
    Price NM, Farrar J, Tran TT, Nguyen TH, Tran TH, Friedland JS.
    J Immunol; 2001 Mar 15; 166(6):4223-30. PubMed ID: 11238675
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
    Liuzzi GM, Mastroianni CM, Santacroce MP, Fanelli M, D'Agostino C, Vullo V, Riccio P.
    J Neurovirol; 2000 Apr 15; 6(2):156-63. PubMed ID: 10822329
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction.
    Thibert KA, Raymond GV, Nascene DR, Miller WP, Tolar J, Orchard PJ, Lund TC.
    PLoS One; 2012 Apr 15; 7(11):e50430. PubMed ID: 23185624
    [Abstract] [Full Text] [Related]

  • 13. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M, Furie KL, Koroshetz WJ, Lee H, Barron M, Lederer M, Wang X, Zhu M, Sorensen AG, Lo EH, Kelly PJ.
    Neurology; 2006 May 23; 66(10):1550-5. PubMed ID: 16717217
    [Abstract] [Full Text] [Related]

  • 14. The CD44 ligand hyaluronic acid is elevated in the cerebrospinal fluid of suicide attempters and is associated with increased blood-brain barrier permeability.
    Ventorp F, Barzilay R, Erhardt S, Samuelsson M, Träskman-Bendz L, Janelidze S, Weizman A, Offen D, Brundin L.
    J Affect Disord; 2016 Mar 15; 193():349-54. PubMed ID: 26796235
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis.
    van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M, Kolk AH, Springer P, Hoepelman AI, Geelen SP, Kimpen JL, Schoeman JF.
    Pediatr Infect Dis J; 2004 Jul 15; 23(7):608-13. PubMed ID: 15247597
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
    Leppert D, Leib SL, Grygar C, Miller KM, Schaad UB, Holländer GA.
    Clin Infect Dis; 2000 Jul 15; 31(1):80-4. PubMed ID: 10913401
    [Abstract] [Full Text] [Related]

  • 17. Predictive value of cerebrospinal fluid matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 concentrations in childhood bacterial meningitis.
    Roine I, Pelkonen T, Bernardino L, Lauhio A, Tervahartiala T, Lappalainen M, Kataja M, Pitkäranta A, Sorsa T, Peltola H.
    Pediatr Infect Dis J; 2014 Jul 15; 33(7):675-9. PubMed ID: 24445831
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-4 in cerebrospinal fluid with blood-brain barrier dysfunction in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis.
    Tsai HC, Chung LY, Chen ER, Liu YC, Lee SS, Chen YS, Sy CL, Wann SR, Yen CM.
    Am J Trop Med Hyg; 2008 Jan 15; 78(1):20-7. PubMed ID: 18187780
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.